Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 1 Sell Rating(s), 7 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $136.91 (9.49% upside)

Current Analysts' Coverage Summary for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015HC WainrightReiterated RatingNeutral$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015RBC CapitalSet Price TargetBuy$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Robert W. BairdReiterated RatingPositive$131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015William BlairReiterated RatingOutperform$126.00 -> $138.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Citigroup Inc.Boost Price TargetBuy$141.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Leerink SwannBoost Price TargetOutperform$131.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Deutsche BankSet Price TargetBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015ZacksReiterated RatingNeutral -> Neutral$136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015BTIG ResearchReiterated RatingBuy$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015TheStreetDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Credit SuisseBoost Price TargetBuy$129.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Maxim GroupDowngradeBuy -> Hold$148.00 -> $121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BarclaysInitiated CoverageEqual Weight$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014JMP SecuritiesReiterated RatingMarket Outperform$115.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Piper JaffrayUpgradeNeutral -> Overweight$87.50 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014Goldman SachsUpgradeNeutral -> Buy$109.00 -> $131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Sanford C. BernsteinBoost Price Target$65.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2013Summer StreetDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2013Cowen and CompanyLower Price TargetNeutral$87.94 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)